Stuart Iain (CIK 1727756) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell VYNE (2,370 shares), Sell VYNE (2,876 shares), Sell VYNE (2,448 shares), Sell VYNE (2,453 shares), Sell VYNE (2,453 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | VYNE Therapeutics Inc. (VYNE) | CHIEF SCIENTIFIC OFFICER | Sell | 2,370 | $1,542 |
| 2026-04-02 | VYNE Therapeutics Inc. (VYNE) | CHIEF SCIENTIFIC OFFICER | Sell | 2,876 | $1,718 |
| 2026-01-05 | VYNE Therapeutics Inc. (VYNE) | CHIEF SCIENTIFIC OFFICER | Sell | 2,448 | $1,420 |
| 2025-10-02 | VYNE Therapeutics Inc. (VYNE) | CHIEF SCIENTIFIC OFFICER | Sell | 2,453 | $834 |
| 2025-07-02 | VYNE Therapeutics Inc. (VYNE) | CHIEF SCIENTIFIC OFFICER | Sell | 2,453 | $4,047 |
| 2025-04-02 | VYNE Therapeutics Inc. (VYNE) | CHIEF SCIENTIFIC OFFICER | Sell | 6,044 | $9,550 |
Source: SEC Form 4 filings · as of 2026-07-02